NYSE · EHC
Encompass Health Corporation
$131.49+$9.41 (+7.7%)
Encompass Health Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
Loading market information…
NASDAQ · PNTG · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
The Pennant Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 2.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
The Pennant Group, Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $0.36. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow The Pennant Group, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The Pennant Group, Inc. is a U.S.-based healthcare provider, delivering a diverse range of services through two core divisions: Home Health and Hospice Services, and Senior Living Services. The company's Home Health segment offers in-home clinical support, encompassing nursing, speech, occupational, and physical therapy, as well as medical social work and home health aide assistance. Its Hospice services focus on providing comprehensive clinical care, education, and counseling to meet the physical, spiritual, and psychosocial needs of terminally ill patients and their families. In its Senior Living division, Pennant provides residential accommodations, organized activities, meals, housekeeping, and aid with daily living tasks for seniors who are either independent or require some support. As of December 31, 2021, the company's extensive operational footprint included 88 home health and hospice agencies and 54 senior living communities, collectively featuring 4,127 senior living units. These facilities are located across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was established in 2019 and maintains its corporate headquarters in Eagle, Idaho.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:26 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2025 | May 6, 2025 | $0.27+22.73% vs estimate | $209.84M+4.16% vs estimate |
|---|
| Q4 2024 | Feb 27, 2025 | $0.240.0% vs estimate | $188.89M+1.65% vs estimate |
|---|
| Q3 2024 | Nov 6, 2024 | $0.26+13.04% vs estimate | $180.69M-2.88% vs estimate |
|---|
THE ANALYST VIEW
7 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 4 contributors · Median target $45.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$131.49+$9.41 (+7.7%)
Encompass Health Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.69% below the high.
$186.32+$2.21 (+1.2%)
The Ensign Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.53% below the high.
$49.68+$0.62 (+1.26%)
PACS Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 1.39% below the high.
$541.92+$8.56 (+1.6%)
Chemed Corporation’s quoted price sits in the upper half of its reported 52-week range, 3.61% below the high.
$212.16+$0.37 (+0.17%)
National HealthCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 14.52% below the high.
$13.26+$0.20 (+1.53%)
Aveanna Healthcare Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 9.86% below the high.
$10.27+$0.29 (+2.91%)
Brookdale Senior Living Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.91% below the high.
$124.34+$2.16 (+1.77%)
Addus HomeCare Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.92% below the high.
